ZA975359B - Biochemical analysis of antioxidant function - Google Patents
Biochemical analysis of antioxidant functionInfo
- Publication number
- ZA975359B ZA975359B ZA975359A ZA975359A ZA975359B ZA 975359 B ZA975359 B ZA 975359B ZA 975359 A ZA975359 A ZA 975359A ZA 975359 A ZA975359 A ZA 975359A ZA 975359 B ZA975359 B ZA 975359B
- Authority
- ZA
- South Africa
- Prior art keywords
- lymphocytes
- cell culture
- culture medium
- antioxidant function
- biologically
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title abstract 4
- 230000003078 antioxidant effect Effects 0.000 title abstract 4
- 238000012742 biochemical analysis Methods 0.000 title abstract 2
- 210000004698 lymphocyte Anatomy 0.000 abstract 6
- 239000006143 cell culture medium Substances 0.000 abstract 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 2
- 229960001231 choline Drugs 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 208000002720 Malnutrition Diseases 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008367 deionised water Substances 0.000 abstract 1
- 229910021641 deionized water Inorganic materials 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229910001410 inorganic ion Inorganic materials 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003226 mitogen Substances 0.000 abstract 1
- 235000018343 nutrient deficiency Nutrition 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
- C12Q1/08—Quantitative determination using multifield media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/665,941 US5985665A (en) | 1996-06-19 | 1996-06-19 | Biochemical analysis of antioxidant function of lymphocytes in culture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA975359B true ZA975359B (en) | 1998-12-18 |
Family
ID=24672179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA975359A ZA975359B (en) | 1996-06-19 | 1997-01-01 | Biochemical analysis of antioxidant function |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5985665A (de) |
| EP (1) | EP0925370B1 (de) |
| JP (1) | JP3679133B2 (de) |
| KR (1) | KR100461205B1 (de) |
| CN (1) | CN1109759C (de) |
| AT (1) | ATE230030T1 (de) |
| AU (1) | AU720703B2 (de) |
| CA (1) | CA2258803C (de) |
| DE (1) | DE69718017T2 (de) |
| IL (1) | IL127576A (de) |
| NZ (1) | NZ333231A (de) |
| RU (1) | RU2233323C2 (de) |
| WO (1) | WO1997048821A1 (de) |
| ZA (1) | ZA975359B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW517089B (en) * | 1996-09-03 | 2003-01-11 | Res Dev Foundation | Assessment of intracellular cysteine and glutathione concentrations |
| US6165797A (en) * | 1999-02-19 | 2000-12-26 | Bio-Defense Nutritionals, Inc. | Methods for testing oxidative stress |
| EP1235849A2 (de) * | 1999-12-09 | 2002-09-04 | Genaera Corporation | Asthma bezogene faktoren zur behandlung von atopischen allergien |
| US20050272085A1 (en) * | 2000-09-06 | 2005-12-08 | Hodge Timothy A | Methods for forensic and congenic screening |
| US20030012701A1 (en) * | 2001-07-13 | 2003-01-16 | Sangha Jangbir S. | Insulated specimen sampling and shipping kit |
| US20030154107A1 (en) * | 2002-02-14 | 2003-08-14 | Mark Medvedeff | Preventcare |
| US6689617B1 (en) | 2002-07-30 | 2004-02-10 | Medi-Tech Holdings, Inc. | Agent for detecting malondialdehyde, method of making the same, and test kit for use thereof |
| MX2007014624A (es) * | 2005-05-26 | 2008-03-24 | Pediatrix Medical Group Inc | Formulaciones nutriconales y metodos para proporcionar formulaciones nutricionales. |
| CN110669730B (zh) * | 2019-10-23 | 2022-03-29 | 杭州杰毅麦特医疗器械有限公司 | 一种人外周血淋巴细胞培养基 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4499064A (en) * | 1982-06-03 | 1985-02-12 | Clayton Foundation For Research | Assessment of nutritional status of individuals |
| US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
-
1996
- 1996-06-19 US US08/665,941 patent/US5985665A/en not_active Expired - Lifetime
-
1997
- 1997-01-01 ZA ZA975359A patent/ZA975359B/xx unknown
- 1997-06-18 EP EP97930001A patent/EP0925370B1/de not_active Expired - Lifetime
- 1997-06-18 AU AU33934/97A patent/AU720703B2/en not_active Ceased
- 1997-06-18 AT AT97930001T patent/ATE230030T1/de not_active IP Right Cessation
- 1997-06-18 DE DE69718017T patent/DE69718017T2/de not_active Expired - Fee Related
- 1997-06-18 WO PCT/US1997/010328 patent/WO1997048821A1/en active IP Right Grant
- 1997-06-18 IL IL12757697A patent/IL127576A/xx not_active IP Right Cessation
- 1997-06-18 NZ NZ333231A patent/NZ333231A/xx unknown
- 1997-06-18 CA CA002258803A patent/CA2258803C/en not_active Expired - Fee Related
- 1997-06-18 KR KR10-1998-0710382A patent/KR100461205B1/ko not_active IP Right Cessation
- 1997-06-18 CN CN97195713A patent/CN1109759C/zh not_active Expired - Fee Related
- 1997-06-18 JP JP50316798A patent/JP3679133B2/ja not_active Expired - Fee Related
- 1997-06-18 RU RU99100621/13A patent/RU2233323C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3679133B2 (ja) | 2005-08-03 |
| AU3393497A (en) | 1998-01-07 |
| ATE230030T1 (de) | 2003-01-15 |
| WO1997048821A1 (en) | 1997-12-24 |
| AU720703B2 (en) | 2000-06-08 |
| CN1222940A (zh) | 1999-07-14 |
| KR20000016773A (ko) | 2000-03-25 |
| EP0925370A4 (de) | 2001-08-01 |
| CN1109759C (zh) | 2003-05-28 |
| CA2258803C (en) | 2009-01-13 |
| US5985665A (en) | 1999-11-16 |
| EP0925370A1 (de) | 1999-06-30 |
| DE69718017T2 (de) | 2003-04-30 |
| NZ333231A (en) | 2000-01-28 |
| IL127576A (en) | 2000-12-06 |
| JP2000514287A (ja) | 2000-10-31 |
| CA2258803A1 (en) | 1997-12-24 |
| EP0925370B1 (de) | 2002-12-18 |
| IL127576A0 (en) | 1999-10-28 |
| KR100461205B1 (ko) | 2005-06-13 |
| RU2233323C2 (ru) | 2004-07-27 |
| DE69718017D1 (de) | 2003-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gaston et al. | Fermentation of ethylene glycol by Clostridium glycolicum, sp. n | |
| Borek et al. | Studies on a mutant of Escherichia coli with unbalanced ribonucleic acid synthesis | |
| Forsberg et al. | Effect of phosphate limitation on the morphology and wall composition of Bacillus licheniformis and its phosphoglucomutase-deficient mutants | |
| KR840005012A (ko) | 영양상태 판정법 | |
| Ferry et al. | Nutritional and biochemical characterization of Methanospirillum hungatii | |
| Thompson et al. | Novel phosphoenolpyruvate-dependent futile cycle in Streptococcus lactis: 2-deoxy-D-glucose uncouples energy production from growth | |
| ZA975359B (en) | Biochemical analysis of antioxidant function | |
| CA2195799A1 (en) | Bacterial production of hydrophobic polypeptides | |
| Baker et al. | Nutritional factors in thermophily: a comparative study of bacilli and Euglena | |
| Pate et al. | Asticcacaulis biprosthecum sp. nov. Life cycle, morphology and cultural characteristics | |
| Williams et al. | Enzymes induced in a bacterium by growth on sodium dodecyl sulfate | |
| Terracciano et al. | Enhancement of chemotaxis in Spirochaeta aurantia grown under conditions of nutrient limitation | |
| Morzycka et al. | Methionine overproduction by Saccharomycopsis lipolytica | |
| ES8900068A1 (es) | Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas. | |
| Clark et al. | Guanyl cyclase of bacilluslicheniformis | |
| Eller et al. | STUDIES ON BACTERIAL UTILIZATION OF URONIC ACIDS IV: Alginolytic and Mannuronic Acid Oxidizing Isolates | |
| Beggs et al. | Repression of tryptophanase synthesis in Escherichia coli | |
| Moses et al. | Adenosine 3′: 5′-cyclic monophosphate and catabolite repression in Escherichia coli | |
| Leija et al. | Effect of L-amino acids on Mucor rouxii dimorphism | |
| Reeves et al. | Modulation of isocitrate dehydrogenase activity in Acinetobacter calcoaceticus by acetate | |
| Becker et al. | Chemical composition of the cell wall of Caryophanon latum | |
| Štěpán et al. | Metabolic implications in the elevation of serum activity of intestinal alkaline phosphatase in chronic renal failure | |
| Vasileva et al. | Dry nutrient medium for determination of cell composition of plague microbe strains by calcium-ion consumption. | |
| GALLIGAN et al. | Factors Affecting Catalase Activity in Staphylococcus aureus MF‐31 | |
| Krzemiński et al. | Endogenous metabolism of Staphylococcus aureus |